The outcome measures included (1) relative importance of clinical outcomes; (2) willingness to use each COX-I when presented as the only option; (3) preference for using prophylactic hydrocortisone vs indomethacin; (4) willingness to use any of the COX-Is when all 3 options are available; and (5) relative importance of having family values and preferences included in decision-making. The qualitative component of the interview attempted to identify themes related to the choice of prophylaxis based on participants’ perceptions of the therapeutic value of each COX-I.
Free full text: Click here